Cargando…
Heavy silicone oil tamponade: a multicentre experience
OBJECTIVE: To report multicentred use of the heavy silicone oil Densiron 68 for anatomical reattachment following rhegmatogenous retinal detachment (RRD) repair and its associated complications. METHODS AND ANALYSIS: Patients from seven vitreoretinal units within the UK that underwent RRD repair wit...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743375/ https://www.ncbi.nlm.nih.gov/pubmed/36710637 http://dx.doi.org/10.1136/bmjophth-2022-001018 |
_version_ | 1784848712573386752 |
---|---|
author | Davidson, Max Dowlut, Samir Zhang, Jufen Naderi, Khayam Sandinha, Teresa Wood, Megan Kay Schneiders, Matthew Saidkasimova, Shohista Peart, Shamfa Chaudhuri, Ray Gunda, Manish Saeed, Manzar Heussen, Florian Keller, Johannes Tarafdar, Sonali Chandra, Aman |
author_facet | Davidson, Max Dowlut, Samir Zhang, Jufen Naderi, Khayam Sandinha, Teresa Wood, Megan Kay Schneiders, Matthew Saidkasimova, Shohista Peart, Shamfa Chaudhuri, Ray Gunda, Manish Saeed, Manzar Heussen, Florian Keller, Johannes Tarafdar, Sonali Chandra, Aman |
author_sort | Davidson, Max |
collection | PubMed |
description | OBJECTIVE: To report multicentred use of the heavy silicone oil Densiron 68 for anatomical reattachment following rhegmatogenous retinal detachment (RRD) repair and its associated complications. METHODS AND ANALYSIS: Patients from seven vitreoretinal units within the UK that underwent RRD repair with Densiron 68 between January 2015 and December 2019 were identified. Primary outcome measures were primary and final reattachment rate, retained Densiron and failure rate. Secondary outcome measures were duration of tamponade, final visual acuity (VA) and complications of heavy silicone oil. RESULTS: 134 eyes of 134 patients were involved in the study. Primary surgical success was achieved in 48.5%, while a final reattachment rate of 73.4% was observed. The mean duration of Densiron 68 tamponade was 139.5 days. Mean final VA was 1.01 (range 0–2.9). 8 eyes (6.0%) required long-term topical steroids for anterior uveitis, whereas none of the eyes required long-term pressure-lowering treatment. Emulsification rate was 10.7% (6 eyes). CONCLUSION: This is the largest real-world study on Densiron 68 in the UK. Densiron 68 facilitates tamponade of inferior retinal pathology and may be considered as an option for tamponade of inferior retinal pathologies. |
format | Online Article Text |
id | pubmed-9743375 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-97433752022-12-13 Heavy silicone oil tamponade: a multicentre experience Davidson, Max Dowlut, Samir Zhang, Jufen Naderi, Khayam Sandinha, Teresa Wood, Megan Kay Schneiders, Matthew Saidkasimova, Shohista Peart, Shamfa Chaudhuri, Ray Gunda, Manish Saeed, Manzar Heussen, Florian Keller, Johannes Tarafdar, Sonali Chandra, Aman BMJ Open Ophthalmol Retina OBJECTIVE: To report multicentred use of the heavy silicone oil Densiron 68 for anatomical reattachment following rhegmatogenous retinal detachment (RRD) repair and its associated complications. METHODS AND ANALYSIS: Patients from seven vitreoretinal units within the UK that underwent RRD repair with Densiron 68 between January 2015 and December 2019 were identified. Primary outcome measures were primary and final reattachment rate, retained Densiron and failure rate. Secondary outcome measures were duration of tamponade, final visual acuity (VA) and complications of heavy silicone oil. RESULTS: 134 eyes of 134 patients were involved in the study. Primary surgical success was achieved in 48.5%, while a final reattachment rate of 73.4% was observed. The mean duration of Densiron 68 tamponade was 139.5 days. Mean final VA was 1.01 (range 0–2.9). 8 eyes (6.0%) required long-term topical steroids for anterior uveitis, whereas none of the eyes required long-term pressure-lowering treatment. Emulsification rate was 10.7% (6 eyes). CONCLUSION: This is the largest real-world study on Densiron 68 in the UK. Densiron 68 facilitates tamponade of inferior retinal pathology and may be considered as an option for tamponade of inferior retinal pathologies. BMJ Publishing Group 2022-12-08 /pmc/articles/PMC9743375/ /pubmed/36710637 http://dx.doi.org/10.1136/bmjophth-2022-001018 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Retina Davidson, Max Dowlut, Samir Zhang, Jufen Naderi, Khayam Sandinha, Teresa Wood, Megan Kay Schneiders, Matthew Saidkasimova, Shohista Peart, Shamfa Chaudhuri, Ray Gunda, Manish Saeed, Manzar Heussen, Florian Keller, Johannes Tarafdar, Sonali Chandra, Aman Heavy silicone oil tamponade: a multicentre experience |
title | Heavy silicone oil tamponade: a multicentre experience |
title_full | Heavy silicone oil tamponade: a multicentre experience |
title_fullStr | Heavy silicone oil tamponade: a multicentre experience |
title_full_unstemmed | Heavy silicone oil tamponade: a multicentre experience |
title_short | Heavy silicone oil tamponade: a multicentre experience |
title_sort | heavy silicone oil tamponade: a multicentre experience |
topic | Retina |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743375/ https://www.ncbi.nlm.nih.gov/pubmed/36710637 http://dx.doi.org/10.1136/bmjophth-2022-001018 |
work_keys_str_mv | AT davidsonmax heavysiliconeoiltamponadeamulticentreexperience AT dowlutsamir heavysiliconeoiltamponadeamulticentreexperience AT zhangjufen heavysiliconeoiltamponadeamulticentreexperience AT naderikhayam heavysiliconeoiltamponadeamulticentreexperience AT sandinhateresa heavysiliconeoiltamponadeamulticentreexperience AT woodmegankay heavysiliconeoiltamponadeamulticentreexperience AT schneidersmatthew heavysiliconeoiltamponadeamulticentreexperience AT saidkasimovashohista heavysiliconeoiltamponadeamulticentreexperience AT peartshamfa heavysiliconeoiltamponadeamulticentreexperience AT chaudhuriray heavysiliconeoiltamponadeamulticentreexperience AT gundamanish heavysiliconeoiltamponadeamulticentreexperience AT saeedmanzar heavysiliconeoiltamponadeamulticentreexperience AT heussenflorian heavysiliconeoiltamponadeamulticentreexperience AT kellerjohannes heavysiliconeoiltamponadeamulticentreexperience AT tarafdarsonali heavysiliconeoiltamponadeamulticentreexperience AT chandraaman heavysiliconeoiltamponadeamulticentreexperience |